One orange prescription pill bottle on a doctor's office desk, clinic, pharmacy, or hospital setting. Bottle has pills spilling out. Pharmacy, medicine, healthcare concepts. Window in background. No people.
Researchers at Karolinska Institutet have unveiled a groundbreaking sequencing method that can detect antibiotic resistance within the same working day. The technique, named s5PSeq, allows for rapid identification of bacterial responses to antibiotics, providing a crucial tool in the fight against antibiotic resistance.
This innovative method evaluates how bacterial ribosomes react shortly after exposure to antibiotics, offering a molecular readout of growth. Unlike traditional culture methods, which can take days, s5PSeq delivers results within minutes. The study, published in Cell Reports Methods, demonstrates that s5PSeq can differentiate between erythromycin-resistant and sensitive strains of Clostridioides difficile after just ten minutes of treatment.
The ability to detect characteristic “stalling” patterns in bacterial RNA enables physicians to identify antibiotic susceptibility long before visible growth differences occur. This rapid assessment could significantly enhance clinical decision-making, especially in critical care environments.
Integration into Clinical Practices
A notable advantage of s5PSeq is its compatibility with portable Nanopore sequencing devices, which are increasingly utilized in diagnostic and research laboratories worldwide. This compatibility suggests a promising future for integrating rapid molecular testing into routine clinical workflows, making timely and informed treatment decisions more accessible.
“Faster, phenotypic diagnostics are essential if we are to address antibiotic resistance effectively. Our method shows that reliable molecular readouts can be obtained in hours rather than days,” stated Vicent Pelechano, senior researcher at SciLifeLab and senior author of the study.
The researchers are advancing their work by adapting s5PSeq for direct testing of complex patient samples, eliminating the need for prior culturing. Collaborating with Karolinska University Hospital, they aim to expand the method’s application to additional pathogens and antibiotics to assess its efficacy in real-world clinical settings.
Future Steps and Impact
As the team continues its research, the next phase involves evaluating how well s5PSeq performs outside controlled laboratory conditions. “These ongoing studies will help determine how s5PSeq can support faster and more informed treatment decisions,” explained Honglian Liu, PhD and first author of the study.
With antibiotic resistance becoming an increasing global health concern, the development of rapid, accurate diagnostic methods like s5PSeq represents a vital step toward improving patient outcomes. The ability to quickly identify resistance patterns can facilitate more effective treatment strategies, potentially saving lives and reducing the burden of antibiotic-resistant infections.
The streamlined, nanopore-compatible 5PSeq protocol for rapid phenotypic antimicrobial sensitivity testing could herald a new era in antimicrobial diagnostics, making significant contributions to public health initiatives aimed at combating antibiotic resistance.
